ARIAD’s petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Government Circuit ARIAD Pharmaceuticals, Inc. and its own co-plaintiffs today announced that the U.S.S. Patent No. ARIAD is the exclusive licensee of the patents and technology. In 2006, the jury in the U.S. The jury awarded damages to the plaintiffs predicated on U.S. Sales of these two drugs through the year 2019, when the patent expires. The jury verdict was upheld in 2007 by Judge Rya W then. Zobel of the District Court who also within favor of the plaintiffs.Accurate and rapid approach to diagnosing bacterial meningitis University of Sydney researchers in Westmead Millennium Institute develop a precise and rapid approach to diagnosing bacterial meningitis. Several hundred serious cases of bacterial meningitis are diagnosed in Australians every year. Bacterial meningitis is a medical emergency that will require immediate analysis and treatment, however doctors have faced difficulty in diagnosis always, both in adults and children. Professor Tania Sorrell and her group at Westmead Millennium Institute can see an instant and effective diagnostic for identifying bacterial meningitis using metabonomics. Metabonomics may be the study of the chemical substance composition of body fluids and tissues.